MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1378/chest.14-0604

Медицинская библиотека · Chest · 2014

Response.

Miño-Izquierdo Lucia, Guerrero-Mauvecin Juan, Villar-Gómez Natalia, Hernández Marta, Carrasco Susana, Castro-Gonzalez Rodrigo, Cannata Pablo, Sanchez-Niño Maria D, Ortiz Alberto, Sanz Ana B

Письмо в редакциюКомментарийПеревод в очереди

Аннотация

INTRODUCTION

Remdesivir was the first antiviral drug approved to treat severe coronavirus disease 2019 (COVID-19). Nephrotoxicity was observed during preclinical development and longer duration of remdesivir therapy was associated with acute kidney injury (AKI) in patients with COVID-19, but its nephrotoxicity has been recently disputed.

METHODS

Remdesivir cytotoxicity was assessed in murine and human proximal tubular cells cultured in 2-D and 3-D models, as well as in a mouse model of acute kidney injury.

RESULTS

We now show that clinically relevant concentrations of remdesivir are cytotoxic to murine and human proximal tubular cells, either immortalized or in primary culture. Cytotoxicity was observed both in 2-D cultures and in spheroids and had morphological and functional features of necrosis. While mitochondrial dysfunction was observed, this appeared to be secondary to cytotoxicity and not a driver of cytotoxicity. Cell death could not be prevented by targeting proapoptotic caspases, nor by inhibiting necroptosis or ferroptosis programmed necrosis. Remdesivir metabolites were not cytotoxic. Interestingly, a short course of remdesivir that was not nephrotoxic by itself increased the severity of AKI induced by a cytokine storm elicited by bacterial lipopolysaccharide in mice. This is a clinically relevant context of use that may explain discrepancies related to the nephrotoxicity potential of short courses of remdesivir.

CONCLUSION

Remdesivir induces necrotic tubular cell death resistant to current interventions targeting programmed cell death, that becomes clinically relevant in the presence of permissive kidney hyperinflammation.

Для цитирования: Miño-Izquierdo Lucia, Guerrero-Mauvecin Juan, Villar-Gómez Natalia, Hernández Marta, Carrasco Susana, Castro-Gonzalez Rodrigo, Cannata Pablo, Sanchez-Niño Maria D, Ortiz Alberto, Sanz Ana B. Response.. Chest. 2014. DOI: 10.1378/chest.14-0604.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.